Location of Repository

Clinical problems caused by obesity

By Ioannis Kyrou and Martin O. Weickert

Abstract

Over the past few decades the incidence of obesity has doubled worldwide and current\ud estimates classify more than 1.5 billion adults as overweight and at least 500 million of them as\ud clinically obese, with body mass index (BMI) over 25 kg/m2 and 30 kg/m2, respectively. Obesity\ud prevalence rates are steadily rising in the majority of the modern Western societies, as well as in the\ud developing world. Moreover, alarming trends of weight gain are reported for children and adolescents,\ud undermining the present and future health status of the pediatric population. To highlight the\ud related threat to public health, the World Health Organization has declared obesity a global epidemic,\ud also stressing that it remains an under-recognized problem of the public health agenda

Topics: RC
Publisher: MDText.com, Inc
Year: 2010
OAI identifier: oai:wrap.warwick.ac.uk:3401

Suggested articles

Preview

Citations

  1. (2009). 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet.
  2. (1991). A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep.
  3. (2006). A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis.
  4. (2006). A proposal for the cutoff point of waist circumference for the diagnosis of metabolic syndrome in the Japanese population. Diabetes Care.
  5. (2008). A prospective study of waist circumference and body mass index in relation to colorectal cancer incidence. Cancer Causes Control.
  6. (2005). A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease.
  7. (1999). A role for preadipocytes as macrophage-like cells. FASEB J.
  8. (2003). A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes. Diabetes.
  9. (2008). A systemic review of obstructive sleep apnea and its implications for anesthesiologists. Anesth Analg.
  10. (2007). Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation.
  11. (2007). Accuracy of anthropometric indicators of obesity to predict cardiovascular risk. J Clin Endocrinol Metab.
  12. (2006). Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol.
  13. (2010). Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol Cell Endocrinol.
  14. (2009). Adipokines in liver diseases. Hepatology.
  15. (2008). Adipokines in osteoarthritis: friends or foes of cartilage homeostasis? Joint Bone Spine.
  16. (2007). Adipose tissue as an immunological organ: Toll-like receptors, C1q/TNFs and CTRPs. Trends Immunol.
  17. (2007). Adipose tissue distribution and risk of metabolic disease: does thiazolidinedione-induced adipose tissue redistribution provide a clue to the answer? Diabetologia
  18. (1994). Adolescent body mass index and infertility caused by ovulatory disorder.
  19. (2006). Adult weight change and risk of postmenopausal breast
  20. (2009). Adverse cardiovascular events during treatment with pioglitazone and rosiglitazone: population based cohort study. BMJ.
  21. (2001). Altered macrophage-like functions of preadipocytes in inflammation and genetic obesity. J Cell Physiol.
  22. (2006). Altered respiratory physiology in obesity. Can Respir J.
  23. (1989). and the risk of symptomatic gallstones in middle-aged women.
  24. (2007). Anthropometric factors and risk of endometrial cancer: the European prospective investigation into cancer and nutrition. Cancer Causes Control.
  25. (2009). Antidiabetic therapies affect risk of pancreatic cancer. Gastroenterology.
  26. (2002). Are the fat more jolly? Ann Behav Med
  27. (2000). Are the obese at greater risk for depression?
  28. (2005). Assessing obesity: are ethnic differences in body mass index and waist classification criteria justified? Obes Rev.
  29. (2006). Assessing the outcome of nonalcoholic steatohepatitis? It's time to get serious. Hepatology.
  30. (2009). Association between common mental disorder and obesity over the adult life course.
  31. (2006). Association between obesity and psychiatric disorders in the US adult population. Arch Gen Psychiatry.
  32. (2008). Association between weight perception and psychological distress.
  33. (2003). Asthma and atopy in overweight children. Thorax.
  34. (1988). Banting lecture 1988. Role of insulin resistance in human disease. Diabetes.
  35. (2002). Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes
  36. (2004). Bariatric surgery: a systematic review and meta-analysis.
  37. (2006). Barriers to routine gynecological cancer screening for White and African-American obese women. Int J Obes (Lond).
  38. (2005). beta-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis. J Clin Endocrinol Metab.
  39. (1981). Biliary lipid composition in obesity.
  40. (1996). Body mass and breast cancer. Relationship between method of detection and stage of disease.
  41. (2000). Body mass and probability of pregnancy during assisted reproduction treatment: retrospective study. BMJ
  42. (2002). Body mass and stage of breast cancer at diagnosis.
  43. (1994). Body mass index and ovulatory infertility. Epidemiology
  44. (2006). Body mass index history and risk of type 2 diabetes: results from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Am J Clin Nutr.
  45. (2008). Body mass index in adolescence in relation to cause-specific mortality: a follow-up of 230,000 Norwegian adolescents.
  46. (1999). Body mass index in young men and the risk of subsequent knee and hip osteoarthritis.
  47. (2007). Body mass index, weight change, and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort. Cancer Epidemiol Biomarkers Prev.
  48. (1998). body size, and risk of endometrial cancer.
  49. (1999). Body weight, body mass index, and incident symptomatic osteoarthritis of the hand, hip, and knee. Epidemiology.
  50. (2008). Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet.
  51. (1999). Body-mass index and mortality in a prospective cohort of U.S. adults.
  52. (2001). BΜΙ in childhood and its association with height gain, timing of puberty, and final height. Pediatr Res.
  53. (2008). Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies. Lancet.
  54. (2007). Carlsson LM; Swedish Obese Subjects Study. Effects of bariatric surgery on mortality in Swedish obese subjects.
  55. (2006). Central adiposity, regional fat distribution, and the risk of cholecystectomy in
  56. (2008). Changes in depression following gastric banding: a 5- to 7-year prospective study. Obes Surg.
  57. (2009). Childhood obesity and the timing of puberty. Trends Endocrinol. Metab.
  58. (2003). Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest.
  59. (2006). Chronic stress at work and the metabolic syndrome: prospective study. BMJ
  60. (2006). chronic stress, and obesity. Prog Brain Res.
  61. (2001). Clinical features and natural history of nonalcoholic steatosis syndromes. Semin Liver Dis.
  62. (2002). Clinical practice. Obstructive sleep apnea.
  63. (2009). Clinical review: The pathogenetic role of cortisol in the metabolic syndrome: a hypothesis. J Clin Endocrinol Metab.
  64. (2009). Combined randomised controlled trial experience of malignancies in studies using insulin glargine. Diabetologia.
  65. (1999). Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR) Diabet Med.
  66. (2009). Common mental disorder and obesity: insight from four repeat measures over 19 years: prospective Whitehall II cohort
  67. (2004). Consensus Workshop Group. Type 2 diabetes in the young: the evolving epidemic: the international diabetes federation consensus workshop. Diabetes Care.
  68. (2004). consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies.
  69. (2006). Cryptogenic cirrhosis and NAFLD: are they related? Am
  70. (1990). Decreased sex hormone binding globulin (SHBG) and insulin-like growth factor binding protein (IGFBP-1) in extreme obesity. Clin Endocrinol (Oxf).
  71. (2010). Decreased survival of subjects with elevated liver function tests during a 28-year follow-up. Hepatology.
  72. (2009). Depression and anxiety among US adults: associations with body mass index. Int J Obes (Lond).
  73. (2008). Depression and anxiety in the United States: findings from the 2006 Behavioral Risk Factor Surveillance System. Psychiatr Serv.
  74. (2009). Depression and Anxiety: Their Predictive Function for Weight Loss in Obese Individuals. Obes Facts
  75. (2009). Depression and body mass index, a u-shaped association. BMC Public Health.
  76. (2003). depression and health-related quality of life after jejunoileal bypass: a 25-year follow-up study of 20 female patients. Obes Surg
  77. (2003). Depression in association with severe obesity: changes with weight loss. Arch Intern Med
  78. (2008). Depressive symptoms and change in abdominal obesity in older persons. Arch Gen Psychiatry.
  79. (1996). Depressive symptoms in overweight and obese older adults: a test of the "jolly fat" hypothesis. J Psychosom Res.
  80. (2002). Dermatological complications of obesity.
  81. (2004). Determinants of gallbladder kinetics in obesity. Dig Dis Sci.
  82. (2009). Diabetes and cancer. Endocr Relat Cancer.
  83. (2006). Diabetes and obesity: the twin epidemics. Nat Med
  84. (2000). Diabetes mellitus and cancer.
  85. (2006). diabetes, and risk of prostate cancer: results from the prostate cancer prevention trial. Cancer Epidemiol Biomarkers Prev.
  86. (2009). Diabetes: diabetes therapy and cancer risk. Nat Rev Endocrinol.
  87. (1998). diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med.
  88. (1998). Diagnosis and interpretation of steatosis and steatohepatitis. Semin Diagn Pathol.
  89. (2003). Different glycemic indexes of breakfast cereals are not due to glucose entry into blood but to glucose removal by tissue. Am J Clin Nutr.
  90. (2001). Do stress reactions cause abdominal obesity and comorbidities? Obes Rev
  91. (2008). Does depression cause obesity? A meta-analysis of longitudinal studies of depression and weight control. J Health Psychol.
  92. (2009). Does diabetes therapy influence the risk of cancer? Diabetologia.
  93. (2008). Does obesity play a major role in the pathogenesis of sleep apnoea and its associated manifestations via inflammation, visceral adiposity, and insulin resistance? Arch Physiol Biochem.
  94. (2008). Does the metabolic syndrome add to the diagnosis and treatment of cardiovascular disease? Nat Clin Pract Cardiovasc Med.
  95. (2007). Drugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis. Cochrane Database Syst Rev.
  96. (2007). eating and the reward system. Physiol Behav
  97. (1998). Effect of insulin on basal and cholecystokinin-stimulated gallbladder motility in humans. J Hepatol.
  98. (2004). Effect of normal-fat diets, either medium or high in protein, on body weight in overweight subjects: a randomised 1-year trial. Int J Obes Relat Metab Disord.
  99. (1993). Effect of obesity and fertility status on sex steroid levels in men. Urology
  100. (2006). Effect of physical activity and body size on survival after diagnosis with colorectal cancer.
  101. (2007). Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes.
  102. (1995). Effect of weight loss and body position on pulmonary function and gas exchange abnormalities in morbid obesity. Int J Obes Relat Metab Disord.
  103. (2007). Effect of weight reduction in obese patients diagnosed with knee osteoarthritis: a systematic review and meta-analysis. Ann Rheum Dis.
  104. (2003). Effects of free fatty acids (FFA) on glucose metabolism: significance for insulin resistance and type 2 diabetes. Exp Clin Endocrinol Diabetes
  105. (2004). Effects of obesity upon genioglossus structure and function in obstructive sleep apnoea. Eur Respir J.
  106. (2005). Effects of subfertility cause, smoking and body weight on the success rate of IVF. Hum Reprod
  107. (2009). Effects of surgical weight loss on measures of obstructive sleep apnea: a meta-analysis. Am
  108. (2007). Effects on insulin secretion and insulin action of a 48-h reduction of plasma free fatty acids with acipimox in nondiabetic subjects genetically predisposed to type 2 diabetes. Am J Physiol Endocrinol Metab.
  109. (2010). Endocrine aspects of obstructive sleep apnea. J Clin Endocrinol Metab.
  110. (2007). Endocrinology of adipose tissue - an update. Horm Metab Res.
  111. (2009). Endometrial cancer and obesity: epidemiology, biomarkers, prevention and survivorship. Gynecol Oncol.
  112. (1996). Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity. Nat Med.
  113. (2009). Epidemiological evidence for the links between sleep, circadian rhythms and metabolism. Obes Rev.
  114. (2007). Epidemiology and natural history of NAFLD and NASH. Clin Liver Dis.
  115. (1997). Epidemiology of coagulation factors, inhibitors and activation markers: The Third Glasgow MONICA Survey. II. Relationships to cardiovascular risk factors and prevalent cardiovascular disease.
  116. (2004). Epidemiology of osteoarthritis in Australia. Med
  117. (2004). Evidence supporting routine polysomnography before bariatric surgery. Obes Surg.
  118. (2006). Examining the evidence for recent secular changes in the timing of puberty in U.S. children in light of increases in the prevalence of obesity. Mol Cell Endocrinol
  119. (2001). Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report
  120. (1997). Factors associated with gallstone disease in the MICOL experience. Multicenter Italian Study on Epidemiology of Cholelithiasis. Hepatology.
  121. (1988). Factors associated with osteoarthritis of the knee in the first national Health and Nutrition Examination Survey (HANES I). Evidence for an association with overweight, race, and physical demands of work.
  122. (1998). Fasting gall bladder volume and lithogenicity in relation to glucose tolerance, total and intra-abdominal fat masses in obese non-diabetic subjects. Int J Obes Relat Metab Disord.
  123. (1989). Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake. Metabolism
  124. (2007). Fat distribution and storage: how much, where, and how?
  125. (1994). fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care.
  126. (2008). Fatty liver disease: predictors of nonalcoholic steatohepatitis and gallbladder disease in morbid obesity. Obes Surg.
  127. (1975). Fatty liver: biochemical and clinical considerations. Am J Dig Dis.
  128. (1999). Fecundability in relation to body mass and menstrual cycle patterns. Epidemiology
  129. (2006). Federation (IDF) Consensus Worldwide Definition of the Metabolic Syndrome.
  130. (1987). Fibrinogen and risk of cardiovascular disease. The Framingham Study.
  131. (1993). Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature. Ann Intern Med.
  132. (1996). Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. ECAT Study Group. European Concerted Action on Thrombosis and Disabilities. Circulation.
  133. (2001). Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.
  134. (2006). Finnish Diabetes Prevention Study Group. Sustained reduction 49 in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet.
  135. (2005). Finnish diabetes prevention study. Physical activity in the prevention of type 2 diabetes: the Finnish diabetes prevention study. Diabetes.
  136. (2006). From fat to inflammation. Gastroenterology.
  137. (2006). Gallbladder cancer worldwide: geographical distribution and risk factors.
  138. (1998). Gallbladder motility and gallstone formation in obese patients following very low calorie diets. Use it (fat) to lose it (well). Int J Obes Relat Metab Disord.
  139. (2000). Gallbladder motility and lithogenesis in obese patients during diet-induced weight loss. Dig Dis Sci.
  140. (2005). Gallbladder pathology in morbid obesity. Obes Surg.
  141. (1999). Gallbladder volume in adults and its relationship to age, sex, body mass index, body surface area and gallstones. An epidemiologic study in a nonselected population in France. Digestion.
  142. (1992). Gallbladder volume in adults, and relationship to age, sex, body mass index, and gallstones: a sonographic population study.
  143. (2006). Gallstone disease: Epidemiology of gallbladder stone disease. Best Pract Res Clin Gastroenterol.
  144. (2006). Gallstone formation after weight loss following gastric banding in morbidly obese Dutch patients. Obes Surg
  145. (2006). Gender differences in the metabolic syndrome and their role for cardiovascular disease. Clin Res Cardiol.
  146. (2006). Genes or environment to determine alcoholic liver disease and non-alcoholic fatty liver disease. Liver Int.
  147. (2007). GI epidemiology: nonalcoholic fatty liver disease. Aliment Pharmacol Ther.
  148. (2004). Glucocorticoids and 11beta-hydroxysteroid dehydrogenase in adipose tissue. Recent Prog Horm Res.
  149. (2007). Health risks associated with overweight and obesity. Obes Rev.
  150. (2003). Health Survey for England. London: Department of Health,
  151. (2006). Heart disease risk determines menopausal age rather than the reverse. J Am Coll Cardiol.
  152. (2010). Heart failure events with rosiglitazone in type 2 diabetes: data from the RECORD clinical trial. Eur Heart J.
  153. (2003). Hepatic glucose metabolism in humans--its role in health and disease. Best Pract Res Clin Endocrinol Metab.
  154. (2006). Hepatic histology in obese patients undergoing bariatric surgery. J Hepatol.
  155. (2009). High protein diets decrease total and abdominal fat and improve CVD risk profile in overweight and obese men and women with elevated triacylglycerol. Nutr Metab Cardiovasc Dis.
  156. (2004). House of Commons Health Committee. Obesity. London: The Stationery Office.
  157. (2005). Hypercoagulability in the metabolic syndrome. Curr Opin Pharmacol.
  158. (2005). IDF Epidemiology Task Force Consensus Group. The metabolic syndrome--a new worldwide definition. Lancet.
  159. (1990). Ilstrup DM, Melton LJ 3rd. Idiopathic symptomatic osteoarthritis of the hip and knee: a population-based incidence study. Mayo Clin Proc.
  160. (2005). Impact of cereal fibre on glucose-regulating factors. Diabetologia.
  161. (2008). Impact of male obesity on infertility: a critical review of the current literature. Fertil Steril.
  162. (2009). Impact of obesity on women's health. Fertil Steril.
  163. (2004). Impact of overweight and underweight on assisted reproduction treatment. Hum Reprod
  164. (2001). Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Arch Intern Med.
  165. Improving reproductive performance in overweight/obese women with effective weight management. Hum Reprod Update
  166. (1999). Incidence and risk factors for radiographic knee osteoarthritis in middle-aged women: the Chingford Study. Arthritis Rheum.
  167. (2001). Increased body mass index has a deleterious effect on in vitro fertilization outcome.
  168. (2008). Increased expression and activity of the transcription factor FOXO1 in nonalcoholic steatohepatitis. Diabetes.
  169. (2005). Increased fat mass compensates for insulin resistance in abdominal obesity and type 2 diabetes: a positron-emitting tomography study. Diabetes.
  170. (1990). Increased volume and decreased emptying of the gallbladder in large (morbidly obese, tall normal, and muscular normal) people. Gastroenterology.
  171. (2000). Increases in leptin levels, sympathetic drive, and weight gain in obstructive sleep apnea. Am J Physiol Heart Circ Physiol.
  172. (2004). Independent and opposite associations of waist and hip circumferences with diabetes, hypertension and dyslipidemia: the AusDiab Study. Int J Obes Relat Metab Disord.
  173. (2009). Infertility treatment outcome in sub groups of obese population. Reprod Biol Endocrinol.
  174. (2004). Inflamed about obesity. Nat Med.
  175. (2006). Inflammation and insulin resistance.
  176. (2006). Inflammation and metabolic disorders. Nature.
  177. (2002). Inflammation in atherosclerosis. Nature.
  178. (2007). Inflammation, obesity, and the metabolic syndrome. Horm Metab Res.
  179. (2003). Influence of body mass index on outcomes and treatment-related toxicity in patients with colon carcinoma.
  180. (2002). Influence of obesity on the development of osteoarthritis of the hip: a systematic review. Rheumatology (Oxford).
  181. (2006). Influence of obesity on timing of puberty.
  182. (2003). Innate immunity in the liver. Curr Opin Gastroenterol.
  183. (2009). Insulin glargine controversy: a tribute to the editorial team at Diabetologia. Diabetes.
  184. (2009). Insulin glargine use and short-term incidence of malignancies-a population-based follow-up study in Sweden. Diabetologia.
  185. (2006). Insulin resistance causes human gallbladder dysmotility. J Gastrointest Surg.
  186. (2010). Insulin Signal Transduction in Normal Cells and its Role in Carcinogenesis. Exp Clin Endocrinol Diabetes.
  187. (2009). insulin-like growth factor-I, and risk of breast cancer in postmenopausal women. J Natl Cancer Inst.
  188. (2006). Interactions of the hormones leptin, ghrelin, adiponectin, resistin, and PYY3-36 with the reproductive system. Fertil Steril.
  189. (2004). Interleukin-6 and insulin sensitivity: friend or foe? Diabetologia.
  190. (2009). Interleukin-6 is a significant predictor of radiographic knee osteoarthritis: The Chingford Study. Arthritis Rheum.
  191. (2006). Intra-abdominal obesity: an untreated risk factor for Type 2 diabetes and cardiovascular disease.
  192. (2009). Inverse relation between dietary fiber intake and visceral adiposity in overweight Latino youth. Am J Clin Nutr.
  193. (2005). Inverse relationship between plasminogen activator inhibitor-I activity and adiponectin in overweight and obese women. Interrelationship with visceral adipose tissue, insulin resistance, HDL-chol and inflammation. Thromb Haemost.
  194. (2008). Is concomitant cholecystectomy necessary in obese patients undergoing laparoscopic gastric bypass surgery? Surg Endosc.
  195. (2002). Is obesity associated with early sexual maturation? A comparison of the association in American boys versus girls. Pediatrics.
  196. (2004). Is obesity associated with early sexual maturation? Pediatrics
  197. (2003). Is obesity associated with major depression? Results from the Third National Health and Nutrition Examination Survey. Am J Epidemiol.
  198. (2007). Is routine cholecystectomy indicated for asymptomatic cholelithiasis in patients undergoing gastric bypass? Obes Surg.
  199. (2008). Jolly fat or sad fat? Subtyping non-eating disordered overweight and obesity along an affect dimension. Appetite.
  200. (1976). Jolly fat: relation between obesity and psychoneurosis in general population.
  201. (1980). Jolly fat' revisited. J Psychosom Res.
  202. (2009). La Vecchia C. Epidemiology of biliary tract cancers: an update. Ann Oncol.
  203. (2010). Leptin receptor modulation of adiposity and fertility. Trends Endocrinol Metab.
  204. (2008). Link between body fat and the timing of puberty. Pediatrics
  205. (2007). Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am J Physiol Endocrinol Metab.
  206. (2006). Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology
  207. (2007). Long-term mortality after gastric bypass surgery.
  208. (2010). Long-term mortality in nonalcoholic fatty liver disease: is liver histology of any prognostic significance? Hepatology.
  209. (2009). Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis. CMAJ.
  210. (1999). Long-term weight patterns and risk for cholecystectomy in women. Ann Intern Med
  211. (2002). Longitudinal changes of body mass index, spirometry and diffusion in a general population. Eur Respir J.
  212. (2000). Longitudinal study of moderate weight change and sleep-disordered
  213. (1979). Low-density lipoprotein receptor activity in cultured human skin fibroblasts. Mechanism of insulin-induced stimulation.
  214. (1994). lung function, and mortality from cardiovascular disease among the elderly. Am J Epidemiol.
  215. (2000). Major stressful life events in relation to prevalence of undetected type 2 diabetes: the Hoorn Study. Diabetes Care
  216. (2000). Male infertility. Current life style could be responsible for infertility. MMW Fortschr Med
  217. (2008). Male obesity and alteration in sperm parameters. Fertil Steril.
  218. (2009). Male obesity and reproductive potential.
  219. (2007). Mantzoros CS. Leptin in reproduction. Curr Opin Endocrinol Diabetes Obes.
  220. (2006). Mechanisms of Disease: hepatic steatosis in type 2 diabetes--pathogenesis and clinical relevance. Nat Clin Pract Endocrinol Metab.
  221. (2004). Medical consequences of obesity.
  222. (2005). Medications associated with weight gain. Ann Pharmacother.
  223. (1974). Menstrual cycles: fatness as a determinant of minimum weight for height necessary for their maintenance or onset.
  224. (2009). Metabolic control of puberty onset: New players, new mechanisms. Mol Cell Endocrinol.
  225. (2009). Metabolic diseases and associated complications: sex and gender matter! Eur J Clin Invest.
  226. (2007). Metabolic liver disease of obesity and role of adipose tissue in the pathogenesis of nonalcoholic fatty liver disease. World
  227. (2009). Metabolic syndrome and hepatocellular carcinoma: two growing epidemics with a potential
  228. (2008). Metabolic syndrome and incident diabetes: current state of the evidence. Diabetes Care.
  229. (2008). Metabolic syndrome and reproduction: I. testicular function. Gynecol Endocrinol.
  230. Metabolic syndrome: a multiplex cardiovascular risk factor.
  231. (2009). Metabolic syndrome: collapsing under its own weight? Diabet Med.
  232. (2001). Metformin in nonalcoholic steatohepatitis. Lancet.
  233. Metformin in patients with non-alcoholic fatty liver disease: a randomized, controlled trial.
  234. (2007). Million Women Study Collaboration. Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ
  235. (2008). Million Women Study Collaborators. Relationship between body mass index and length of hospital stay for gallbladder disease. J Public Health (Oxf).
  236. (2009). Molecular signatures of obstructive sleep apnea in adults: a review and perspective. Sleep.
  237. (2009). Mortality and disability: the effect of overweight and obesity. Int J Obes (Lond).
  238. (1997). Narrow hips and broad waist circumferences independently contribute to increased risk of non-insulin-dependent diabetes mellitus. J Intern Med.
  239. (2005). Natural history of NAFLD: remarkably benign in the absence of cirrhosis. Gastroenterology.
  240. (2000). Neuroendocrine abnormalities in visceral obesity.
  241. (1999). Neuroendocrine regulation and actions of leptin. Front Neuroendocrinol.
  242. New insights into the pathophysiology of nonalcoholic fatty liver disease. Ann Hepatol.
  243. (2009). No evidence of increased risk of malignancies in patients with diabetes treated with insulin detemir: a meta-analysis. Diabetologia.
  244. (2009). Nocturnal levels of ghrelin and leptin and sleep in chronic insomnia. Psychoneuroendocrinology.
  245. (2009). Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management. Hepatology.
  246. (2007). Nonalcoholic fatty liver disease as a complication of insulin resistance. Med Clin North Am
  247. (2001). Nonalcoholic fatty liver disease in the Indian subcontinent: a medical consequence of globalization?
  248. (1999). Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology.
  249. (2006). Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology.
  250. (2002). Nonalcoholic fatty liver disease.
  251. (2002). Nonalcoholic fatty liver disease. Gastroenterology.
  252. (1980). Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc.
  253. (2003). Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology.
  254. (2004). Nonalcoholic steatohepatitis. Semin Liver Dis.
  255. (2003). Nutrition and the Prevention of Chronic Diseases.
  256. (2006). Obesity and androgens: facts and perspectives. Fertil Steril
  257. (2004). Obesity and breast cancer: a review of the literature. Breast.
  258. (2004). obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer.
  259. (2009). Obesity and cancer: the role of dysfunctional adipose tissue. Cancer Epidemiol Biomarkers Prev.
  260. (2008). Obesity and cancer.
  261. (2009). Obesity and depression or anxiety. BMJ.
  262. (1966). Obesity and depression: results from the longitudinal
  263. (2004). Obesity and dermatology. Clin Dermatol.
  264. (2008). Obesity and diabetes epidemics: cancer repercussions. Adv Exp Med Biol.
  265. (2003). Obesity and hip osteoarthritis: the weight of the evidence is increasing.
  266. (2009). Obesity and its relationship to infertility in men and women. Obstet Gynecol Clin North Am.
  267. (2008). Obesity and knee osteoarthritis: new insights provided by body composition studies. Obesity (Silver Spring).
  268. (1988). Obesity and knee osteoarthritis. The Framingham Study. Ann Intern Med.
  269. (2008). Obesity and mental disorders in the general population: results from the world mental health surveys. Int J Obes (Lond).
  270. (2007). Obesity and mortality in men with locally advanced prostate cancer: analysis of RTOG 85-31.
  271. (2010). Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology.
  272. (2008). Obesity and osteoarthritis in knee, hip and/or hand: an epidemiological study in the general population with 10 years follow-up. BMC Musculoskelet Disord.
  273. (2009). Obesity and osteoarthritis: disease genesis and nonpharmacologic weight management. Med Clin North Am.
  274. (2009). Obesity and osteoarthritis: is leptin the link? Arthritis Rheum.
  275. (2006). Obesity and osteoarthritis: more complex than predicted! Ann Rheum Dis.
  276. (2008). Obesity and osteoarthritis: what are the links? Joint Bone Spine.
  277. (2007). Obesity and prostate cancer: a role for adipokines. Eur Urol.
  278. (2007). Obesity and prostate cancer: making sense out of apparently conflicting data. Epidemiol Rev.
  279. (1997). Obesity and reproduction. Hum Reprod.
  280. (2003). Obesity and reproductive disorders in women. Hum Reprod Update.
  281. (2006). Obesity and sexual quality of life. Obesity (Silver Spring).
  282. (2009). Obesity and sexuality in women. Obstet Gynecol Clin North Am.
  283. (2008). Obesity and the lung: 2. Obesity and sleep-disordered breathing. Thorax.
  284. (2008). Obesity and the lung: 3. Obesity, respiration and intensive
  285. (2008). Obesity and the lung: 4. Obesity and asthma. Thorax.
  286. (2006). Obesity and the metabolic syndrome: the stress on society.
  287. (2007). Obesity and the risk of gallbladder cancer: a meta-analysis. Br
  288. (2007). Obesity and the skin: skin physiology and skin manifestations of obesity. J Am Acad Dermatol.
  289. (1994). Obesity as a risk factor for osteoarthritis of the hand and wrist: a prospective study.
  290. (2008). Obesity effects on depression: systematic review of epidemiological studies.
  291. (2004). Obesity in adolescence and adulthood and the risk of adult mortality. Epidemiology.
  292. (2000). Obesity in anaesthesia and intensive care.
  293. (2005). Obesity in Asia Collaboration (OAC). Ethnic comparisons of obesity in the Asia-Pacific region: protocol for a collaborative overview of cross-sectional studies. Obes Rev.
  294. (2006). Obesity in the Neolithic era: a Greek female figurine. Obes Surg.
  295. (1998). Obesity in the Paleolithic era? The Venus of Willendorf. Endocr Pract
  296. (2002). Obesity is a risk factor for dyspnea but not for airflow obstruction. Arch Intern Med.
  297. (2000). Obesity is a risk factor for early pregnancy loss after IVF or ICSI. Acta Obstet Gynecol Scand
  298. (2003). Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest.
  299. (2008). Obesity Management Task Force of the European Association for the Study of Obesity. Management of obesity in adults: European clinical practice guidelines. Obes Facts.
  300. (2007). Obesity-associated improvements in metabolic profile through expansion of adipose
  301. (2008). Obesity-associated liver disease.
  302. (2007). Obesity-induced inflammation: a metabolic dialogue in the language of inflammation.
  303. (2003). Obesity-induced inflammatory changes in adipose tissue.
  304. (2003). obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.
  305. (2007). Obesity, metabolic syndrome, and prostate cancer. Am J Clin Nutr.
  306. (2006). Obstetric outcomes after in vitro fertilization in obese and morbidly obese women. Obstet Gynecol
  307. (2002). Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med.
  308. (2007). Obstructive sleep apnea: an update on mechanisms and cardiovascular consequences. Nutr Metab Cardiovasc Dis.
  309. (2003). Obstructive sleep apnea: implications for cardiac and vascular
  310. (2006). Obstructive sleep apnea: re-evaluating our index of severity. Sleep Med.
  311. (2003). Obstructive sleep-related breathing disorders in patients evaluated for bariatric surgery. Obes Surg.
  312. (2005). Old fat, make way for new fat. Nat Med.
  313. (2004). Organization: Obesity: preventing and managing the global epidemic. Report of a WHO Consultation.
  314. (2004). Organization. Comparative Quantification of Health Risks: Global and Regional Burden of Disease Attributable to Selected Major Risk Factors.
  315. (1999). Organization. Definition, Diagnosis, and Classification of Diabetes Mellitus and its Complications: Report of a WHO Consultation.
  316. (2008). Osteoarthritis and obesity: experimental models. Joint Bone Spine.
  317. (2006). Osteoarthritis: epidemiology. Best Pract Res Clin Rheumatol
  318. other putative markers of inflammation, and weight gain in middle-aged adults--the ARIC study. Atherosclerosis Risk in Communities. Obes Res.;
  319. (2008). Overweight and obesity are associated with psychiatric disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Psychosom Med.
  320. (2001). Overweight as an avoidable cause of cancer in Europe. Int
  321. (2005). Oyarce AM. Insulin acutely decreases hepatic fatty acid synthase activity. Cell Metab.
  322. (2006). PAI-1 and the metabolic syndrome: links, causes, and consequences. Arterioscler Thromb Vasc Biol.
  323. (2002). Pathogenesis of steatohepatitis. Best Pract Res Clin Gastroenterol.
  324. (2004). Pathogenesis of type 2 diabetes mellitus. Med Clin North Am
  325. (2007). Pathology of nonalcoholic fatty liver disease.
  326. (2002). Patient delay and stage of diagnosis among breast cancer patients in Germany - a population based study.
  327. (2009). Pediatric non-alcoholic fatty liver disease: preventive and therapeutic value of lifestyle intervention.
  328. (2009). Perioperative safety in the longitudinal assessment of bariatric surgery.
  329. (1993). Pharyngeal fat in obstructive sleep apnea. Am Rev Respir Dis.
  330. (2006). physical activity, and the risk of pancreatic cancer in the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev.
  331. (2010). physically demanding work and traumatic knee injury are major risk factors for knee osteoarthritis--a population-based study with a follow-up of 22 years. Rheumatology (Oxford).
  332. Physiology of obesity and effects on lung function.
  333. (2007). Pi-Sunyer FX; Diabetes Prevention Program Research Group. Body size and shape changes and the risk of diabetes in the diabetes prevention program. Diabetes.
  334. (2005). Point: visceral adiposity is causally related to insulin resistance. Diabetes Care.
  335. (1990). Portal" adipose tissue as a generator of risk factors for cardiovascular disease and diabetes. Arteriosclerosis
  336. (2008). Possible complications and treatment of nonalcoholic steatohepatitis (NASH).
  337. (2010). Poynard T; LIDO Study Group. Long-term efficacy of rosiglitazone in nonalcoholic steatohepatitis: results of the fatty liver improvement by rosiglitazone therapy (FLIRT 2) extension trial. Hepatology.
  338. (2008). Practice Committee of American Society for Reproductive Medicine. Obesity and reproduction: an educational bulletin. Fertil Steril.
  339. (2002). Prediction of the individual follicle-stimulating hormone threshold for gonadotropin induction of ovulation in normogonadotropic anovulatory infertility: an approach to increase safety and efficiency. Fertil Steril
  340. (2009). Predictors of gallstone formation after bariatric surgery: a multivariate analysis of risk factors comparing gastric bypass, gastric banding, and sleeve gastrectomy. Surg Endosc.
  341. (2003). Predominant role of reduced beta-cell sensitivity to glucose over insulin resistance in impaired glucose tolerance. Diabetologia.
  342. (2003). Prevalence and predictors of asymptomatic liver disease in patients undergoing gastric bypass surgery. Arch Surg.
  343. (2005). Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology.
  344. (1994). Prevalence of chronic liver disease in the general population of northern Italy: the Dionysos Study. Hepatology.
  345. Prevalence of fatty liver in a general population of Okinawa,
  346. (2006). Prevalence of gallbladder stone disease in obese children and adolescents: influence of the degree of obesity, sex, and pubertal development. J Pediatr Gastroenterol Nutr.
  347. (1982). Prevalence of gallstones in obese Caucasian American women. Int J Obes.
  348. (2004). Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology.
  349. (2005). Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults. Diabet Med.
  350. (2009). Prevention of type 2 diabetes in adults with impaired glucose tolerance:
  351. (2003). Prospective association between obesity and depression: evidence from the Alameda County Study. Int J Obes Relat Metab Disord
  352. (2007). Prospective effect of job strain on general and central obesity in the Whitehall II Study.
  353. (2004). Prospective study of abdominal adiposity and gallstone disease in US men.
  354. (2007). Prospective study of adiposity and weight change in relation to prostate cancer incidence and
  355. (1999). Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women. J Natl Cancer Inst.
  356. (2008). Prospective weight change and colon cancer risk in male US health professionals.
  357. (2003). Psychosocial functioning before and after laparoscopic adjustable gastric banding: a cross-sectional study. Obes Surg.
  358. (2009). Psychosocial functioning improves following adolescent bariatric surgery. Obesity (Silver Spring).
  359. (2003). Psychosocial functioning in the obese before and after weight reduction: construct validity and responsiveness of the obesity related Problems scale. Int J Obes Relat Metab Disord
  360. (2007). Pubertal development in obese children and adolescents.
  361. (2006). Pulmonary function and abdominal adiposity in the general population. Chest.
  362. (2000). Pulmonary function is a longterm predictor of mortality in the general population: 29-year follow-up of the Buffalo Health Study. Chest.
  363. Pulmonary physiology and pathophysiology in obesity.
  364. Putting insulin glargine and malignancies into perspective.
  365. (1990). Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy.
  366. (2005). Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease. Hepatology.
  367. (2008). Reassessment of the cutoff values of waist circumference and visceral fat area for identifying Japanese subjects at risk for the metabolic syndrome. Diabetes Res Clin Pract.
  368. (2008). Recent experiences of weight-based stigmatization in a weight loss surgery population: psychological and behavioral correlates. Obesity (Silver Spring).
  369. (1999). Recent weight gain in patients with newly diagnosed obstructive sleep apnea. J Hypertens.
  370. (1994). Recurrence of sleep apnea without concomitant weight increase 7.5 years after weight reduction surgery. Chest.
  371. (2000). Redefining type 2 diabetes: “diabesity” or “obesity dependent diabetes mellitus”? Obes Rev
  372. (2006). Reduced fertility among overweight and obese men. Epidemiology.
  373. (2007). Regulation of inflammation-related genes in human adipose tissue.
  374. (2000). Regulation of proliferation and apoptosis by the insulin-like growth factor I receptor. Growth Horm IGF Res.
  375. (1974). Regulation of the diurnal rhythm of rat liver beta-hydroxy-beta-methylglutaryl coenzmye A reductase activity by insulin, glucagon, cyclic AMP and hydrocortisone. Arch Biochem Biophys.
  376. (1999). Relation of sleepiness to respiratory disturbance index: the Sleep Heart Health Study. Am J Respir Crit Care Med.
  377. (2007). Relationship between stress, eating behavior, and obesity. Nutrition.
  378. (1979). Relationship of obesity to bile lithogenicity in man. Ann Surg.
  379. (2001). Relationship of serum leptin concentration and other measures of adiposity with gallbladder disease. Hepatology.
  380. (1995). Relationships of generalized and regional adiposity to insulin sensitivity in men. J Clin Invest.
  381. (2007). Research Fund/American Institute for Cancer Research. Food, Nutrition, and Physical Activity, and the Prevention of Cancer: A Global Perspective.
  382. (1974). Respiratory compliance in obese patients. Anesthesiology.
  383. (2008). Review article: current management of non-alcoholic fatty liver disease and nonalcoholic steatohepatitis. Aliment Pharmacol Ther.
  384. (2000). Review article: gall-bladder motor function in obesity. Aliment Pharmacol Ther.
  385. (2010). Risk factors for onset of osteoarthritis of the knee in older adults: a systematic review and meta-analysis. Osteoarthritis Cartilage.
  386. (2000). Risk factors for the incidence and progression of radiographic knee osteoarthritis. Arthritis Rheum.
  387. (2009). risk factors, and consequences of obstructive sleep apnea and short sleep duration. Prog Cardiovasc Dis.
  388. (2009). Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study. Diabetologia.
  389. (1988). Risk of ovulatory infertility in relation to body weight. Fertil Steril
  390. (1992). Risk of symptomatic gallstones in women with severe obesity.
  391. (2007). Role of adipocytokines in hepatic fibrogenesis. J Gastroenterol Hepatol.
  392. (2007). Role of obesity and adiposity in polycystic ovary syndrome.
  393. (2004). Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach.
  394. (2009). Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial. Lancet.
  395. (2005). Sanyal AJ; Nonalcoholic Steatohepatitis Clinical Research Network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology.
  396. (2009). SDRN Epidemiology Group. Use of insulin glargine and cancer incidence in Scotland: A study from the Scottish Diabetes Research Network Epidemiology Group. Diabetologia
  397. (2000). search for type 2 diabetes susceptibility genes in four American populations.
  398. (2000). Sex hormones, obesity, fat distribution, type 2 diabetes and insulin resistance: epidemiological and clinical correlation. Int J Obes Relat Metab Disord.
  399. (2000). Sex steroid hormones, sex hormone-binding globulin, and obesity in men and women. Horm Metab Res.
  400. (2005). Shaffer EA.Epidemiology and risk factors for gallstone disease: has the paradigm changed in the 21st century? Curr Gastroenterol Rep.
  401. (2008). Short sleep duration and weight gain: a systematic review. Obesity (Silver Spring).
  402. (2006). Signalling mechanisms linking hepatic glucose and lipid metabolism. Diabetologia.
  403. (1989). Sites and sizes of fat deposits around the pharynx in obese patients with obstructive sleep apnoea and weight matched controls. Eur Respir J.
  404. (1994). Sleep apnea and sleep disruption in obese patients. Arch Intern Med.
  405. (1999). Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep.
  406. (1993). Snoring and sleep apnoea in men: association with central obesity and hypertension. Int J Obes Relat Metab Disord.
  407. (2007). Sollano JD; Asia-Pacific Working Party on NAFLD. Non-alcoholic fatty liver disease in the Asia-Pacific region: definitions and overview of proposed guidelines. J Gastroenterol Hepatol.
  408. (2005). Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest.
  409. (2004). Splanchnic lipolysis in human obesity. J Clin Invest.
  410. (2002). Stature and pubertal stage assessment in American boys: the 1988-1994 Third National Health and Nutrition Examination Survey. J Adolesc Health.
  411. (2009). Steatocholecystitis and fatty gallbladder disease. Dig Dis Sci.
  412. (1998). Steatohepatitis: a tale of two "hits"? Gastroenterology.
  413. (2009). Stress and disorders of the stress system. Nat Rev Endocrinol
  414. (2007). Stress and weight change in university students in the United Kingdom. Physiol Behav
  415. (1998). Stress-related cortisol secretion in men: relationships with abdominal obesity and endocrine, metabolic and hemodynamic abnormalities.
  416. (1997). Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat. Diabetes.
  417. (2007). Subfecundity in overweight and obese couples. Hum Reprod
  418. (2009). Sympathetic neural mechanisms in human cardiovascular health and disease. Mayo Clin Proc.
  419. (2009). Symptomatic gallstones after sleeve gastrectomy. Surg Endosc.
  420. (1999). Thaete FL. Effects of weight loss on regional fat distribution and insulin sensitivity in obesity. Diabetes.
  421. (2007). The AASM Manual for the scoring of sleep and associated events, rules, terminology and technical specifications. Westchester, IL: American Academy of Sleep Medicine;
  422. (2009). The association between obesity and anxiety disorders in the population: a systematic review and meta-analysis. Int J Obes (Lond).
  423. (2006). The burden of diabetes mellitus among US youth: prevalence estimates from the SEARCH for Diabetes in Youth Study. Pediatrics.
  424. (2007). The burden of overweight and obesity-related ill health in the UK. Obes Rev.
  425. (1988). The changing relationship of obesity and disability,
  426. (1989). The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med.
  427. (1999). The disease burden associated with overweight and
  428. (2001). The effect of gender on the relationship between body fat distribution and lung function. J Clin Epidemiol.
  429. (2009). The effect of obesity and lower serum prostate-specific antigen levels on prostate-cancer screening results in American men. BJU Int.
  430. (2008). The effect of thiazolidinediones on BMD and osteoporosis. Nat Clin Pract Endocrinol Metab.
  431. (1999). The effects of adiposity and weight change on forced expiratory volume decline in a longitudinal study of adults. Int J Obes Relat Metab Disord.
  432. (2006). The effects of body mass index on lung volumes. Chest.
  433. (1998). The effects of body mass on lung volumes, respiratory mechanics, and gas exchange during general anesthesia. Anesth Analg.
  434. (2000). The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. Endocr Rev.
  435. (2004). The epidemiology of central fat distribution in relation to disease. Nutr Rev
  436. (2006). The epidemiology of nonalcoholic fatty liver disease in adults.
  437. (2008). The epidemiology of obesity: the size of the problem.
  438. (2009). The impact of maternal obesity on the incidence of adverse pregnancy outcomes in high-risk term pregnancies.
  439. (2005). The impact of obesity on active life expectancy
  440. (2007). The impact of obesity on female reproductive function. Obes Rev.
  441. (2005). The impact of obesity on the incidence and treatment of gynecologic cancers: a review. Obstet Gynecol Surv.
  442. (2009). The influence of glucose-lowering therapies on cancer risk in type 2 diabetes. Diabetologia.
  443. The liver in obesity.
  444. (1976). The mechanism of increased gallstone formation in obese human subjects. Surgery.
  445. (2006). The metabolic syndrome and adipocytokines. FEBS Lett.
  446. (2007). The metabolic syndrome: how to approach differing definitions. Med Clin North Am.
  447. (2005). The metabolic syndrome: requiescat in pace. Clin Chem.
  448. (2005). The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia.
  449. (2009). The metabolic syndrome: useful concept or clinical tool? Report of a WHO Expert Consultation. Diabetologia.
  450. (2005). The myth of the metabolic syndrome. Diabetologia.
  451. (2008). The new WCRF/AICR report: Food, Nutrition, Physical Activity and the Prevention of Cancer: A Global Perspective
  452. (1993). The occurrence of sleep-disordered breathing among middle-aged adults.
  453. (2000). The perils of portliness: causes and consequences of visceral adiposity. Diabetes
  454. (2009). The pickwickian syndrome-obesity hypoventilation syndrome. Clin Chest Med.
  455. (2003). The prevalence and etiology of elevated aminotransferase levels in the United States. Am
  456. (1952). The relation of obesity to menstrual disturbances.
  457. (2001). The relation of type 2 diabetes and cancer. Diabetes Technol Ther.
  458. (2007). The relationship between obesity and injuries among U.S. adults. Am J Health Promot.
  459. (1996). The role of gallbladder emptying in gallstone formation during diet-induced rapid weight loss. Hepatology.
  460. (2003). The Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised
  461. (2008). The second World Cancer Research Fund/American Institute for Cancer Research expert report. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Proc Nutr Soc.
  462. (2002). The underlying basis for obesity: relationship to
  463. (2010). Thiazolidinedione Drugs and Cardiovascular Risks. A Science Advisory From the American Heart Association and American College of Cardiology Foundation. Circulation.
  464. (2006). Thiazolidinediones for nonalcoholic steatohepatitis-promising but not ready for prime time.
  465. (2003). Total hip replacement due to osteoarthritis: the importance of age, obesity, and other modifiable risk factors.
  466. (1996). Total respiratory system, lung, and chest wall mechanics in sedated-paralyzed postoperative morbidly obese patients. Chest.
  467. (2009). Tsigos C. Stress hormones: physiological stress and regulation of metabolism. Curr Opin Pharmacol.
  468. (2006). Tumour necrosis factor alpha signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice. Gut.
  469. (1995). Upper airway and soft tissue anatomy in normal subjects and patients with sleep-disordered breathing. Significance of the lateral pharyngeal walls. Am J Respir Crit Care Med.
  470. (2008). Ursodeoxycholic acid in the prevention of gallstone formation after bariatric surgery: a meta-analysis. Obes Surg.
  471. (2007). Use of insulin sensitizers in NASH. Endocrinol Metab Clin North Am
  472. (1999). Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med.
  473. (2006). visceral obesity, and metabolic complications.
  474. (2004). Waist and hip circumferences and all-cause mortality: usefulness of the waist-to-hip ratio? Int J Obes Relat Metab Disord.
  475. (2007). Waist circumference is associated with pulmonary function in normal-weight, overweight, and obese subjects. Am J Clin Nutr.
  476. (1999). Weight change and duration of overweight and obesity in the incidence of type 2 diabetes. Diabetes Care
  477. (2002). Weight control and physical activity in cancer prevention. Obes Rev.
  478. (1997). Weight gain and longitudinal changes in lung function in steel workers.
  479. (1995). Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med.
  480. (1992). Weight loss reduces the risk for symptomatic knee osteoarthritis in women. The Framingham Study. Ann Intern Med.
  481. (2000). Weight loss, not aerobic exercise, improves pulmonary function in older obese men. J Gerontol A Biol Sci Med Sci.
  482. (2009). When "flawed" translates into "flood": the unproven association between cancer incidence and glargine insulin therapy. Oncologist.
  483. (2008). WHO recognition of the global obesity epidemic.
  484. (2009). Whole-grain intake and cereal fiber are associated with lower abdominal adiposity in older adults.
  485. (1991). Why domen get gallstones? Roles of abdominal fat and hyperinsulinaemia.
  486. (2008). Why metabolic syndrome criteria have not made prime time: a view from the clinic. Int J Obes (Lond).
  487. (1997). Women's reproductive health: the role of body mass index in early and adult life. Int J Obes Relat Metab Disord.
  488. (2006). Worldwide trends in childhood overweight and obesity. Int J Pediatr Obes.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.